IPCA Laboratories share news and announcements
NSE: IPCALABBSE: 524494Pharmaceuticals & BiotechnologyMid Cap
Last close ₹1,953.30up ₹49.80 (2.62%)BSE ₹1,951.25
Share price at the NSE close on 23 Oct 2026. Previous close ₹1,903.50.
52-week range of traded prices to 23 Oct 2026
₹1,251.60Low, 24 Oct 2025₹2,038.00High, 18 Sep 2026
- Next results date: the board meets on 5 Nov 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹49,556 Cr229th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 13 Aug 2026
- 37.8
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 29 May 2026
- 6.1
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.31%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 13 Aug 2026
- 17.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 13 Aug 2026
- 17.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 29 May 2026
- 0.07
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 3,18,78151.9% delivered
IPCA Laboratories board meetings
123 filed, newest first. Page 3 of 3.
Jul 2011
11 Jul · Board meeting
Inter-alia, to take on record the Unaudited Financial Results for the 1st Quarter ended June 30, 2011.
May 2011
13 May · Board meeting
Inter-alia, to consider : (1) The Audited Financial Results for the financial year ended March 31, 2011; and (2) Recommendation of final dividend for the financial year ended March 31, 2011.
Jan 2011
12 Jan · Board meeting
Inter-alia, to consider the following : (1) Unaudited Financial Results for 3rd Quarter and nine months ended December 31, 2010; (2) 2nd Interim Dividend for the financial year 2010-11; (3) Allotment of equity shares on exercise of options under Ipca Laboratories Ltd. - Employees Stock Option Scheme - 2006 (ESOS).
Oct 2010
7 Oct · Board meeting
Inter-alia, to consider the following: (1) Unaudited Financial Results for the quarter and half year ended September 30, 2010; and (2) Interim Dividend for the financial year 2010-11.
Jun 2010
29 Jun · Board meeting
Inter-alia, to take on record the Unaudited Financial Results for the 1st Quarter ended June 30, 2010.
May 2010
10 May · Board meeting
Inter alia, to consider (1)The Audited Financial Results for the financial year ended March 31, 2010; and (2) recommendation of final dividend for the financial year ended March 31, 2010.
Feb 2010
12 Feb · Board meeting
Inter alia, to fix the ' Record Date' for deciding the Members entitlement of sub-divided shares.
Jan 2010
8 Jan · Board meeting
Inter-alia, to consider the following: (1) Unaudited Financial Results for 3rd Quarter and nine months ended December 31, 2009. (2) 2nd Interim Dividend for the financial year 2009-10. (3) Allotment of equity shares on exercise of options under Ipca Laboratories Ltd. - Employees Stock Option Scheme - 2006 (ESOS); and (4). Sub-division (share split) of the equity shares of the Company. Further, the Company has decided to fix January 28, 2010, as the 'Record Date' for the Members entitlement of 2nd Interim dividend for the financial year 2009-10 that may be declared at the said Board Meeting.
Dec 2009
1 Dec · Board meeting
Inter-alia, to consider the allotment of equity shares on exercise of options under Ipca Laboratories ltd.- Employees Stock Option Scheme - 2006 (ESOS).
Oct 2009
28 Oct · Board meeting
Inter-alia, to consider closure of the on-going Buy-back of own fully paid equity shares of the Company from open market purchase through Stock Exchanges.12 Oct · Board meeting
Inter-alia, to consider the following: 1) Unaudited Financial Results for the quarter and half year ended September 30, 2009; and 2) Interim Dividend for the financial year 2009-10. Further, the Company has decided to fix November 03, 2009 as the 'Record Date' for the Members entitlement of interim dividend for the financial year 2009-10 that may be declared at the said Board Meeting.
Jul 2009
16 Jul · Board meeting
Meeting on 30 Jul 2009: “Unaudited Financial Results for the Qtr ended June 30, 2009”
May 2009
20 May · Board meeting
Inter-alia to consider 1) The audited financial results for the financial year ended March 31, 2009. 2) Recommendation of final dividend for the financial year ended March 31,2009.
Jan 2009
9 Jan · Board meeting
Inter-alia, to consider the following: (1) Unaudited Financial Results for 3rd quarter and nine months ended December 31, 2008; and (2) 2nd Interim Dividend for the financial year 2008-09. Further the Company has decided to fix January 28, 2009 as the 'Record Date' for the Members entitlement of 2nd interim dividend for the financial year 2008-09 that may be declared at the said Board Meeting.
Nov 2008
1 Nov · Board meeting
Inter-alia, to consider the following: (1) Buy back of own equity shares of the Company; and (2) Further grant of options to selected permanent employees of the Company under Ipca Laboratories Ltd - Employees Stock Option Scheme-2006 (ESOS) as sanctioned by the shareholders at the Annual General Meeting of the Company held on July 28, 2006 (as amended from time to time).
Oct 2008
22 Oct · Board meeting
Inter-alia, to consider the following: (1) Allotment of equity shares on exercise of options under Ipca Laboratories Ltd. - Employees Stock Option Scheme - 2006 (ESOS). (2) Unaudited Financial Results for the quarter and half year ended September 30, 2008; and (3) Interim Dividend for the financial year 2008-09. Further the Company has decided to fix November 10, 2008 as the 'Record Date' for the Members entitlement of interim dividend for the financial year 2008-09 that may be declared at the said Board Meeting.
Jul 2008
16 Jul · Board meeting
Meeting on 25 Jul 2008: “Unaudited Financial Results for the Qtr ended June 30, 2008”
May 2008
20 May · Board meeting
Inter alia, to consider: (1) The Audited Financial Results for the financial year ended March 31, 2008 and. (2) Recommendation of final dividend for financial year ended March 31, 2008.
Jan 2008
7 Jan · Board meeting
Inter alia, to take on record the Unaudited Financial Results for the 3rd Quarter and nine months ended December 31,2007.
Oct 2007
18 Oct · Board meeting
Inter-alia, to consider the following: 1) Unaudited Financial Results for the quarter and half year ended September 30, 2007; and 2) Interim Dividend for the financial year 2007-08. Further, the Company has decided to fix November 07, 2007 as the 'Record Date' for the Members entitlement of interim dividend for the financial year 2007-08 that may be declared at the said Board Meeting.
Jul 2007
13 Jul · Board meeting
Meeting on 20 Jul 2007: “Unaudited financial results for quarter ended June 30, 2007”
May 2007
18 May · Board meeting
Inter - alia, to consider : (1) the Audited Financial Results for the financial year ended March 31, 2007 ; and (2) recommendation of final dividend for financial year ended March 31, 2007.
Jan 2007
15 Jan · Board meeting
Inter-alia, to take on record the Unaudited Financial Results for the 3rd Quarter and nine months ended December 31,2006.